← FDA DRUG APPROVALS

FDA ANDA · ANDA071424

VERAPAMIL HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA071424
TYPE
ANDA
ORIGINAL APPROVAL
1988-05-25
LATEST ACTION
2002-12-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 120MG · TABLET · ORAL

Approval history

2002-12-16Manufacturing (CMC) · Supplement 12AP
2001-12-28Manufacturing (CMC) · Supplement 11AP
1999-05-05Manufacturing (CMC) · Supplement 10AP
1998-06-23Labeling · Supplement 9AP
1995-03-30Manufacturing (CMC) · Supplement 8AP
1992-08-06Labeling · Supplement 7AP
1992-05-28Labeling · Supplement 6AP
1991-04-22Labeling · Supplement 5AP
1991-02-05Manufacturing (CMC) · Supplement 3AP
1991-02-05Manufacturing (CMC) · Supplement 4AP
1990-08-03Labeling · Supplement 1AP
1988-05-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →